[Implication of bronchopulmonary cancer patients in thoracic oncology].

Implication des patients atteints d’un cancer broncho-pulmonaire en oncologie thoracique.
Cancer broncho-pulmonaire Clinical decision-making Lung cancer Patient-reported outcome Quality of life Qualité de vie Élaboration des décisions cliniques

Journal

Revue des maladies respiratoires
ISSN: 1776-2588
Titre abrégé: Rev Mal Respir
Pays: France
ID NLM: 8408032

Informations de publication

Date de publication:
Dec 2021
Historique:
received: 11 05 2021
accepted: 01 10 2021
pubmed: 17 11 2021
medline: 15 12 2021
entrez: 16 11 2021
Statut: ppublish

Résumé

Changed relationships between patient and health care provider have given patients a greater role in their care. Nowadays, they have the opportunity to be involved in decision-making regarding any diagnostic, therapeutic or monitoring intervention related to their disease. Access to international scientific data through the web, the activity of different patient associations, and the information given by their referring physician can enrich their knowledge about their disease and its possible treatments. In addition to the objective criteria usually assessed, the role currently assumed by patient associations in clinical research helps to identify their expectations. In addition, a number of new tools allow the thoracic oncologist to better understand patients' wishes. Health authorities' use of patient-reported outcomes and patients' use of digital applications contribute to improved survival without any deleterious impact on quality of life. Web applications designed to monitor a patient's toxicities during treatment are now commercially available. To meet our patients' expectations, we are called upon to incorporate these different digital tools into our daily practice.

Identifiants

pubmed: 34782178
pii: S0761-8425(21)00385-5
doi: 10.1016/j.rmr.2021.10.005
pii:
doi:

Types de publication

Journal Article Review

Langues

fre

Sous-ensembles de citation

IM

Pagination

986-992

Informations de copyright

Copyright © 2021 SPLF. Published by Elsevier Masson SAS. All rights reserved.

Auteurs

T Pierret (T)

Service de pneumologie et physiologie, unité d'oncologie thoracique, CHU Grenoble Alpes, CS10217, 38043 Grenoble cedex, France. Electronic address: tpierret@chu-grenoble.fr.

M Giaj-Levra (M)

Service de pneumologie et physiologie, unité d'oncologie thoracique, CHU Grenoble Alpes, CS10217, 38043 Grenoble cedex, France.

E Gobbini (E)

Service de pneumologie et physiologie, unité d'oncologie thoracique, CHU Grenoble Alpes, CS10217, 38043 Grenoble cedex, France.

A-C Toffart (AC)

Service de pneumologie et physiologie, unité d'oncologie thoracique, CHU Grenoble Alpes, CS10217, 38043 Grenoble cedex, France.

D Moro-Sibilot (D)

Service de pneumologie et physiologie, unité d'oncologie thoracique, CHU Grenoble Alpes, CS10217, 38043 Grenoble cedex, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH